InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by ROBERTS JOHN A, Chairman & CEO. Insider active across 2 companies, notably Vyant Bio, Inc.. Cumulatively, 6 disclosures have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €102k. History available since 24 May 2021. The latest transaction was filed on 24 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
5,000 shares@ US$2.028.8% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-029828
Ideal exit: 21 Aug 2022 (T+270)
5,000 shares@ US$2.028.8% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-029828:0
Ideal exit: 21 Aug 2022 (T+270)
10,406 shares@ US$2.4121.0% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-021244:0
Ideal exit: 20 May 2022 (T+270)
10,406 shares@ US$2.4121.0% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-021244
Ideal exit: 20 May 2022 (T+270)
7,440 shares@ US$3.3820.2% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-013101:0
Ideal exit: 18 Feb 2022 (T+270)
7,440 shares@ US$3.3820.2% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-013101
Ideal exit: 18 Feb 2022 (T+270)
6 of 6 declarations
About ROBERTS JOHN A
John A. Roberts is the Chief Executive Officer of Vyant Bio, Inc. He leads the company's operations, focusing on business strategy and growth. His expertise in the biopharmaceutical sector is crucial in guiding Vyant in its development initiatives.
